The Dynamic Nature of Coronary Artery Lesion Morphology Assessed by Serial Virtual Histology Intravascular Ultrasound Tissue Characterization-Reference-Cited by-同舟云学术

The Dynamic Nature of Coronary Artery Lesion Morphology Assessed by Serial Virtual Histology Intravascular Ultrasound Tissue Characterization

Published:2010-04 Issue:15 Volume:55 Page:1590-1597
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kubo Takashi,Maehara Akiko,Mintz Gary S.,Doi Hiroshi,Tsujita Kenichi,Choi So-Yeon,Katoh Osamu,Nasu Kenya,Koenig Andreas,Pieper Michael,Rogers Jason H.,Wijns William,Böse Dirk,Margolis M. Pauliina,Moses Jeffrey W.,Stone Gregg W.,Leon Martin B.

Funder

Volcano Corporation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Natural history and histological classification of atherosclerotic lesions: an update;Stary;Arterioscler Thromb Vasc Biol,2000

2. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly;Burke;N Engl J Med,1997

3. Pathology of the vulnerable plaque;Virmani;J Am Coll Cardiol,2006

4. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions;Virmani;Arterioscler Thromb Vasc Biol,2000

5. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression;Burke;Circulation,2001

Cited by 297 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of vulnerable patient phenotypes and acute coronary syndrome mechanisms;International Journal of Cardiology;2024-11

2. Relationship between plaque burden and plaque vulnerability: Acute coronary syndromes versus chronic coronary syndrome;Journal of Cardiovascular Computed Tomography;2024-09

3. Developing Theoretical Models for Atherosclerotic Lesions: A Methodological Approach Using Interdisciplinary Insights;Life;2024-08-05

4. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis;RMD Open;2024-07

5. Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”;Bleeding, Thrombosis and Vascular Biology;2024-06-26